Table 4.
Serum pro-inflammatory and anti-inflammatory markers in different groups.
| Groups (n = 7) | ||||||
|---|---|---|---|---|---|---|
| Parameters | Control | SFD | MUFAs | PUFAs | MCFAs | SCFAs |
| MDA (nmol/ml) | 4.86 ± 0.16 | 12.12a ± 0.12 | 6.74ab ± 0.1 | 5.71abc ± 0.13 | 8.81abcd ± 0.12 | 6.42abde ± 0.12 |
| TA (µmol/L) | 1.76 ± 0.03 | 0.78a ± 0.02 | 1.21ab ± 0.01 | 1.62abc ± 0.03 | 0.99abcd ± 0.02 | 1.19abde ± 0.01 |
| IL-6 (pg/ml) | 34.14 ± 0.8 | 136.14a ± 2.28 | 71.86ab ± 2.74 | 58.43abc ± 1.73 | 82.14abcd ± 2.33 | 66abde ± 2.45 |
| IL-10 (pg/ml) | 134.93 ± 0.68 | 72.43a ± 2.66 | 92.21ab ± 0.94 | 108.71abc ± 2.53 | 83.5abcd ± 0.49 | 92.5abde ± 0.92 |
Data represent mean ± S.E of observations from seven animals.
a: significant difference from the control group, b: significant difference from long chain-saturated (SFD) group, c: significant difference from monounsaturated (MUFAs) group, d: significant difference from polyunsaturated (PUFAs) group, e: significant difference from medium chain (MCFAs) group. Significance: p < 0.05. MDA: malondialdehyde, TA: Total anti-oxidants, IL-6: interleukin-6, IL-10: interleukin-10, SCFAs: short chain fatty acids. n: number of rats in each group.